THE FREQUENCY OF RELAPSED OR REFRACTORY DISEASE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN CLASSICAL HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW

被引：0
|
作者：
Szabo, S. M. [1 ]
Roop, S. [1 ]
Juarez Garcia, A. [2 ]
Hirji, I [3 ]
机构：
[1] Broad St Hlth Econ & Outcomes Res, Vancouver, BC, Canada
[2] Bristol Myers Squibb, Mexico City, DF, Mexico
[3] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2111
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN39
引用
收藏
页码：A715 / A715
页数：1
相关论文
共 50 条
  • [1] Autologous stem cell transplantation in refractory or relapsed Hodgkin lymphoma
    Afonso, S.
    Carvalhais, I.
    Carneiro, A.
    Araujo, J.
    Principe, F.
    Guimaraes, J. E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S440 - S441
  • [2] HOW I TREAT RELAPSED CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION
    Akay, Olga Meltem
    LEUKEMIA RESEARCH, 2016, 49 : S11 - S11
  • [3] Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
    Domingo-Domenech, Eva
    Sureda, Anna
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [4] Treatment of relapsed Hodgkin lymphoma after autologous stem cell transplantation
    Illes Arpad
    Simon Zsofia
    Udvardy Miklos
    Magyari Ferenc
    Jona Adam
    Miltenyi Zsofia
    ORVOSI HETILAP, 2017, 158 (34) : 1338 - 1345
  • [5] Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
    Zhang, Chen
    Deng, Jili
    Xie, Yan
    Mi, Lan
    Liu, Weiping
    Wang, Xiaopei
    Zhao, Linjun
    Song, Yuqin
    Zhu, Jun
    CANCER MEDICINE, 2023, 12 (09): : 10351 - 10362
  • [6] Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
    Kaloyannidis, Panayotis
    Hertzberg, Mark
    Webb, Kate
    Zomas, Athanasios
    Schrover, Rudolf
    Hurst, Michael
    Jacob, Ian
    Nikoglou, Thalia
    Connors, Joseph M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 540 - 549
  • [7] Outcomes after autologous stem cell transplantation in relapsed or refractory Hodgkin disease: The Duke experience
    Kim, D. W.
    Misra, D.
    Clough, R. W.
    Long, G. D.
    Prosnitz, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease
    Stoneham, S
    Ashley, S
    Pinkerton, CR
    Wallace, WH
    Shankar, AG
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (11) : 740 - 745
  • [9] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
    Crump, M. C.
    Villa, D.
    Kuruvilla, J.
    Kukreti, V
    Franke, N.
    Tsang, R.
    Keating, A.
    HAEMATOLOGICA, 2010, 95 : S25 - S25
  • [10] Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Castagna, Luca
    Carlo-Stella, Carmelo
    Mazza, Rita
    Santoro, Armando
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
12345